Airway clearance solutions market seen reaching $1.81B by 2030

The airway clearance solutions market is projected to grow from $1.06 billion in 2026 to $1.81 billion by 2030, according to The Business Research Company, as chronic respiratory disease, home-based care and portable device demand rise. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth through the forecast period.

Why it matters: - Airway clearance solutions are becoming a bigger part of respiratory care as chronic lung disease, aging populations and home treatment options drive demand. - The market’s forecast growth signals more use of devices and therapies that help patients clear mucus, breathe more efficiently and reduce infection risk.

What happened: - The Business Research Company released its Airway Clearance Solutions Global Market Report 2026. - The report says the market will rise from $0.93 billion in 2025 to $1.06 billion in 2026. - The report projects the market will reach $1.81 billion by 2030. - The report forecasts a 14.3% CAGR from 2026 to 2030.

The details: - Airway clearance solutions include medical devices and therapies designed to loosen, move and remove excess mucus from the respiratory tract. - These solutions support lung function, airway hygiene and overall respiratory health. - They are used in both clinical settings and home settings. - The historical growth case is tied to chronic respiratory illness, an aging population, greater awareness of respiratory health, expanding home healthcare services and better access to respiratory therapies. - The forecast period is shaped by higher demand for home-based respiratory care, more neuromuscular disorders, healthcare infrastructure investment in emerging markets, stronger prevention efforts and wider adoption of new airway clearance treatments. - Expected trends include more home therapy, more portable and wearable devices, customized respiratory care protocols, broader use of non-invasive mucus removal technologies and more long-term respiratory disease management. - A free sample of the report is available here. - The full report is available here.

Between the lines: - Chronic respiratory disease remains the clearest demand driver because airway clearance tools directly target mucus buildup, airway blockage and infection risk. - The move toward portable, wearable and home-based options suggests buyers want treatment that is easier to use outside hospitals. - North America held the largest market share in 2025, but Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - World Health Organization data cited in the report said more than 80 million people in the WHO European Region had chronic respiratory diseases in June 2025, and global COPD cases were projected to rise 23% by 2050.

What's next: - The report says future market growth will likely be tied to preventive respiratory care and broader adoption of innovative airway clearance therapies. - The Business Research Company says the 2026 edition includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated trend analysis.